medigraphic.com
ISSN 2594-1518 (Electronic)
ISSN 1405-0099 (Print)

2018, Number 4

<< Back Next >>

Cir Gen 2018; 40 (4)

Decrease in insulin use in diabetic patients operated on bariatric surgery

Adame-García I, Montoya-Ramírez J, Blas-Azotla R, Méndez-Ibarra JU, Ballesteros-Barrera IF

Language: Spanish
References: 16
Page: 238-242
PDF size: 246.98 Kb.


ABSTRACT

Introduction: Obesity is an abnormal and excessive accumulation of adipose tissue that affects the state of health (WHO), obesity is define as a BMI of 30 kg/m2 or greater. The importance of obesity is the comorbidities associated like diabetes mellitus, hypertension, heart disease, respiratory disease, and others. In recent years has increased the incidence of overweight and obesity and with that the diabetes mellitus. Bariatric surgery has shown an increase in excess weight loos and improvement of comorbidities, including remission of diabetes mellitus. The object of this study is to define the effect of bariatric surgery in patient with diabetes mellitus treated with insulin in a period of five years, in The National Medical Center Hospital 20 de Noviembre, ISSSTE, of Mexico city. Material and methods: In this retrospective, longitudinal, analytic study, with 523 patient undergoing bariatric surgery at The 20 de Noviembre Medical Center Hospital, in a period of 01 January 2011 to 31 October 2016. Only 35 patients were treated whit insulin. Kolmogorov-Smirnov test was performed to determine the distribution of normality of the samples, the Student’s t test was used. Result: 35 obese patients were on insulin treatment, and underwent bariatric surgery, 77% were female and 23% were male, mean age 50 years, suffering from diabetes mellitus with the mean of 10.3 years, the period of time using insulin with a mean of 37.4 months, with a HBA1c of 9.4%, the procedures performed were 20 sleeve gastrectomies, 12 gastric bypasses and 3 gastric bands. Conclusion: The majority of the patient no longer required insulin, 91.4% of patients in our study, the importance lies in the impact on the quality of life, and on the economic impact, we show that bariatric surgery decreases the use of insulin.


REFERENCES

  1. Barja-Fernández S, Folgueira C, Castelao C, Leis R, Casanueva FF, Seoane LM. Peripheral signals mediate the beneficial effects of gastric surgery in obesity. Gastroenterol Res Pract. 2015; 2015: 560938.

  2. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016 (ENSANUT MC 2016). Informe final de resultados. Recuperado de: https://www.insp.mx/ensanut/medio-camino-16.html

  3. Aphramore L, et al. NICE. Weight management: lifestyle services for overweight or obese adults. Public health guideline Published: 28 May 2014. Recuperado de: http://nice.org.uk/guidance/ph53

  4. SAGES Guidelines Committee. SAGES guideline for clinical application of laparoscopic bariatric surgery. Surg Endosc. 2008; 22: 2281-2300.

  5. Andrade-Silva SG, Caranti DA, Sallet JA, Leal LP, Leal AJ, Dâmaso AR. Age and gender may influence the results of roux-en-y gastric bypass? Metabolic syndrome parameters. Arq Gastroenterol. 2014; 51: 171-179.

  6. Sanjay A. Medical Management of obesity. Obesity, Bariatric and Metabolic surgery. Springer; 2016. pp. 39-48.

  7. American Diabetes Association. 7. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018; 41: S65-S72.

  8. English TM, Malkani S, Kinney RL, Omer A, Dziewietin MB, Perugini R. Predicting remission of diabetes after RYGB surgery following intensive management to optimize preoperative glucose control. Obes Surg. 2015; 25: 1-6.

  9. Wang GF, Yan YX, Xu N, Yin D, Hui Y, Zhang JP, et al. Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis. Obes Surg. 2015; 25: 199-208.

  10. Ashrafian H, Harling L, Toma T, Athanasiou C, Nikiteas N, Efthimiou E, et al. Type 1 diabetes mellitus and bariatric surgery: a systematic review and meta-analysis. Obes Surg. 2016; 26: 1697-1704.

  11. Middelbeek RJ, James-Todd T, Patti ME, Brown FM. Short-term insulin requirements following gastric bypass surgery in severely obese women with type 1 diabetes. Obes Surg. 2014; 24: 1442-1446.

  12. Sesión Conjunta Academia Mexicana de Cirugía e Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado. Experiencia en Cirugía Bariátrica CMN 20 de Noviembre. Agosto 2014. Dr. Jesús Montoya Ramírez. Disponible en: https://www.youtube.com/watch?v=nv06lc1L1YA

  13. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004; 292: 1724-1737.

  14. Ricci C, Gaeta M, Rausa E, Asti E, Bandera F, Bonavina L. Long-term effects of bariatric surgery on type II diabetes, hypertension and hyperlipidemia: a meta-analysis and meta-regression study with 5-year follow-up. Obes Surg. 2015; 25: 397-405.

  15. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017; 376: 641-651.

  16. Cefalu WT, Rubino F, Cummings DE. Metabolic surgery for type 2 diabetes: changing the landscape of diabetes care. Diabetes Care. 2016; 39: 857-860.




2020     |     www.medigraphic.com